OTCMKTS:PKPH - Peak Pharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0950 -0.01 (-9.52 %) (As of 03/24/2019 04:00 PM ET)Previous Close$0.0950Today's Range$0.0911 - $0.105052-Week Range$0.0550 - $0.30Volume30,712 shsAverage Volume36,759 shsMarket Capitalization$7.44 millionP/E RatioN/ADividend YieldN/ABeta1.4 ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Peak Pharmaceuticals, Inc. operates as a biopharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THCfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona. Receive PKPH News and Ratings via Email Sign-up to receive the latest news and ratings for PKPH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryCannabis SectorMedical Current SymbolOTCMKTS:PKPH Previous Symbol CUSIPN/A CIKN/A Webwww.peakpharma.com Phone480-659-6404Debt Debt-to-Equity RatioN/A Current Ratio0.04 Quick Ratio0.04Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net Income$-50,000.00 Net MarginsN/A Return on EquityN/A Return on Assets-1,057.04%Miscellaneous Employees1 Outstanding Shares78,360,000Market Cap$7.44 million Next Earnings DateN/A OptionableNot Optionable Peak Pharmaceuticals (OTCMKTS:PKPH) Frequently Asked Questions What is Peak Pharmaceuticals' stock symbol? Peak Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PKPH." Has Peak Pharmaceuticals been receiving favorable news coverage? Media stories about PKPH stock have trended neutral on Sunday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Peak Pharmaceuticals earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the stock's share price in the immediate future. Who are some of Peak Pharmaceuticals' key competitors? Some companies that are related to Peak Pharmaceuticals include Adial Pharmaceuticals (ADIL), GTX (GTXI), Heat Biologics (HTBX), Aileron Therapeutics (ALRN), Q BioMed (QBIO), Acerus Pharmaceuticals (TRLPF), RegeneRx Biopharmaceuticals (RGRX), Genprex (GNPX), SUMMIT THERAPEU/S (SMMT), IMMURON LTD/S (IMRN), Evoke Pharma (EVOK), Fibrocell Science (FCSC), Onconova Therapeutics (ONTX), Citius Pharmaceuticals (CTXR) and Ceapro (CRPOF). What other stocks do shareholders of Peak Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Peak Pharmaceuticals investors own include Micron Technology (MU), NVIDIA (NVDA), Aphria (APHQF), Canopy Growth (CGC), Alibaba Group (BABA), General Electric (GE), OrganiGram (OGRMF), CONSOL Coal Resources (CCR), QUALCOMM (QCOM) and Insys Therapeutics (INSY). Who are Peak Pharmaceuticals' key executives? Peak Pharmaceuticals' management team includes the folowing people: Mr. Neil T. Reithinger, CEO, Pres, CFO, Principal Accounting Officer, Treasurer, Sec. & Director (Age 49) How do I buy shares of Peak Pharmaceuticals? Shares of PKPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Peak Pharmaceuticals' stock price today? One share of PKPH stock can currently be purchased for approximately $0.0950. How big of a company is Peak Pharmaceuticals? Peak Pharmaceuticals has a market capitalization of $7.44 million. Peak Pharmaceuticals employs 1 workers across the globe. What is Peak Pharmaceuticals' official website? The official website for Peak Pharmaceuticals is http://www.peakpharma.com. How can I contact Peak Pharmaceuticals? Peak Pharmaceuticals' mailing address is 14201 N. HAYDEN ROAD SUITE A-1, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-659-6404 or via email at [email protected] MarketBeat Community Rating for Peak Pharmaceuticals (OTCMKTS PKPH)Community Ranking: 3.4 out of 5 ( )Outperform Votes: 54 (Vote Outperform)Underperform Votes: 26 (Vote Underperform)Total Votes: 80MarketBeat's community ratings are surveys of what our community members think about Peak Pharmaceuticals and other stocks. Vote "Outperform" if you believe PKPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PKPH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/24/2019 by MarketBeat.com StaffFeatured Article: Asset Allocation Models, Which is Right For You?